"IMO-9200 for Autoimmune Disease. We have developed a second novel synthetic oligonucleotide antagonist of TLR7, TLR8, and TLR9, IMO-9200, as a drug candidate in clinical development for potential use in selected autoimmune disease indications. In October 2014, we initiated subcutaneous dosing in a Phase 1 clinical trial of IMO-9200. We have also initiated additional preclinical studies of IMO-9200 for a selected autoimmune disease."
Could be saving it for AACR. That's where the company has historically made there announcements and presentations of data. I believe 9200 will be the next piece of news. Milano knows exactly what he's doing. Last 2 orphan announcements came out of left field. An announcement re 9200 and indication such as lupus, accompanied by data which is due now, AND a partner. Let's just say that will wipe out the shorts' 10-cent profit and then some.
Runs this Saturday through next Wednesday. Take advantage of the shorting and buy the daily lows. They will be covering for a higher price. We could get 9200 or combo news next week. GL longs.
You jumped on it too early, luvdick. LOL. 50,000 shares to drop it 4 pennies. You go girl. Nice choice.
Finally, a voice of reason. Thanks, Jackie, but you're talking to the loudmouth in the bar that would be getting his teeth kicked in right now.
What's my "1"? And please give me 3 of yours. Don't forget to include the ones that have already gone up and you went back in your time machine and bought 'em. You don't have a track record. You just fail and then create a new ID. You probably had PLUG at 6, WLT at 6, DRYS at 3.80, PRGN at 5. My picks are there, and they are better than 10%, but I'm all ears for your 15-day track record.
LOL! We all have 'em now and then. Bird is smart. He follows strict trading rules and does pretty good. With regards to IDRA, for me this is a fundamental play. It's not a matter of IF it will go, it's a matter of WHEN it will go. Pull up the last presentation from JPM, and you can see why Goldman and JPM bought it. Management is loaded with people who have nothing left to prove and were compelled to join IDRA and buy enormous amounts of shares. That's the money to follow.
"portends"........he's got long hard things on his mind
Should see 5+. Wouldn't it be great to see a WM breakthrough since it's open=label started back in October. Perhaps 9200 announcement --- indication Lupus, partner. Or combo therapy. We'll see something no doubt.
Milano's town. IDRA is there every year. They'll be talking about TLR platforms and progress for sure. Perfect time for an announcement, and this management knows how to work it. Set up the rolling pins.